MaxCyte, Inc. (MXCT.L)
GBp 346.0
(0.87%)
GBp 346.0
(0.87%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -44.12 Million USD | -112.71% |
| 2022 | -24.66 Million USD | -24.87% |
| 2021 | -16.61 Million USD | -67.09% |
| 2020 | -9.94 Million USD | 14.29% |
| 2019 | -11.6 Million USD | -46.64% |
| 2018 | -7.91 Million USD | 13.53% |
| 2017 | -9.14 Million USD | -251.61% |
| 2016 | -2.6 Million USD | -301.67% |
| 2015 | -647.8 Thousand USD | 45.27% |
| 2014 | -1.18 Million USD | -71.97% |
| 2013 | -688.3 Thousand USD | 62.0% |
| 2012 | -1.81 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -11.16 Million USD | -59.62% |
| 2024 Q2 | -10.88 Million USD | 2.48% |
| 2023 Q1 | -12.21 Million USD | -214.92% |
| 2023 FY | - USD | -112.71% |
| 2023 Q4 | -6.99 Million USD | 45.66% |
| 2023 Q3 | -12.87 Million USD | -6.84% |
| 2023 Q2 | -12.04 Million USD | 1.38% |
| 2022 Q1 | -3.57 Million USD | 19.24% |
| 2022 Q4 | -3.87 Million USD | 30.83% |
| 2022 Q3 | -5.6 Million USD | 27.29% |
| 2022 Q2 | -7.71 Million USD | -115.44% |
| 2022 FY | - USD | -24.87% |
| 2021 FY | - USD | -67.09% |
| 2021 Q1 | -6.04 Million USD | -189.09% |
| 2021 Q2 | -4.08 Million USD | 32.48% |
| 2021 Q4 | -4.43 Million USD | -118.85% |
| 2021 Q3 | -2.02 Million USD | 50.4% |
| 2020 Q1 | -2.76 Million USD | -78.24% |
| 2020 Q4 | -2.09 Million USD | 17.81% |
| 2020 FY | - USD | 14.29% |
| 2020 Q3 | -2.54 Million USD | 10.36% |
| 2020 Q2 | -2.83 Million USD | -2.63% |
| 2019 Q1 | -4.35 Million USD | -131.35% |
| 2019 FY | - USD | -46.64% |
| 2019 Q2 | -4.35 Million USD | 0.0% |
| 2019 Q3 | -1.55 Million USD | 64.33% |
| 2019 Q4 | -1.55 Million USD | 0.0% |
| 2018 Q1 | -2.15 Million USD | 17.25% |
| 2018 Q2 | -2.15 Million USD | 0.0% |
| 2018 Q4 | -1.88 Million USD | 0.0% |
| 2018 FY | - USD | 13.53% |
| 2018 Q3 | -1.88 Million USD | 12.92% |
| 2017 Q1 | -1.96 Million USD | -129.34% |
| 2017 Q2 | -1.96 Million USD | 0.0% |
| 2017 Q3 | -2.6 Million USD | -32.86% |
| 2017 Q4 | -2.6 Million USD | 0.0% |
| 2017 FY | - USD | -251.61% |
| 2016 FY | - USD | -301.67% |
| 2016 Q3 | -856.55 Thousand USD | -89.38% |
| 2016 Q4 | -856.55 Thousand USD | 0.0% |
| 2016 Q2 | -452.3 Thousand USD | 0.0% |
| 2016 Q1 | -452.3 Thousand USD | -622.52% |
| 2015 Q4 | -62.6 Thousand USD | 0.0% |
| 2015 FY | - USD | 45.27% |
| 2015 Q2 | -271.3 Thousand USD | 0.0% |
| 2015 Q1 | -271.3 Thousand USD | -76.57% |
| 2015 Q3 | -62.6 Thousand USD | 76.93% |
| 2014 Q1 | -438.2 Thousand USD | -48.08% |
| 2014 Q4 | -153.65 Thousand USD | 0.0% |
| 2014 FY | - USD | -71.97% |
| 2014 Q3 | -153.65 Thousand USD | 64.94% |
| 2014 Q2 | -438.2 Thousand USD | 0.0% |
| 2013 Q1 | -172.07 Thousand USD | 0.0% |
| 2013 Q4 | -295.92 Thousand USD | -71.97% |
| 2013 FY | - USD | 62.0% |
| 2013 Q3 | -172.07 Thousand USD | 0.0% |
| 2013 Q2 | -172.07 Thousand USD | 0.0% |
| 2012 Q1 | -452.87 Thousand USD | 0.0% |
| 2012 Q3 | -452.87 Thousand USD | 0.0% |
| 2012 Q4 | -172.07 Thousand USD | 62.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | -452.87 Thousand USD | 0.0% |
| 2011 Q4 | -452.87 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|